These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 9581833)

  • 1. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
    Schaber JD; Fang H; Xu J; Grimley PM; Rui H
    Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoic acid induces signal transducer and activator of transcription (STAT) 1, STAT2, and p48 expression in myeloid leukemia cells and enhances their responsiveness to interferons.
    Matikainen S; Ronni T; Lehtonen A; Sareneva T; Melén K; Nordling S; Levy DE; Julkunen I
    Cell Growth Differ; 1997 Jun; 8(6):687-98. PubMed ID: 9186002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells.
    Gooch JL; Herrera RE; Yee D
    Cell Growth Differ; 2000 Jun; 11(6):335-42. PubMed ID: 10910100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages.
    Lehtonen A; Matikainen S; Julkunen I
    J Immunol; 1997 Jul; 159(2):794-803. PubMed ID: 9218597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT1: a modulator of chemotherapy-induced apoptosis.
    Thomas M; Finnegan CE; Rogers KM; Purcell JW; Trimble A; Johnston PG; Boland MP
    Cancer Res; 2004 Nov; 64(22):8357-64. PubMed ID: 15548705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors.
    Takauji R; Iho S; Takatsuka H; Yamamoto S; Takahashi T; Kitagawa H; Iwasaki H; Iida R; Yokochi T; Matsuki T
    J Leukoc Biol; 2002 Nov; 72(5):1011-9. PubMed ID: 12429724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The induction and activation of STAT1 by all-trans-retinoic acid are mediated by RAR beta signaling pathways in breast cancer cells.
    Shang Y; Baumrucker CR; Green MH
    Oncogene; 1999 Nov; 18(48):6725-32. PubMed ID: 10597280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant melanoma associates with deficient IFN-induced STAT 1 phosphorylation.
    Kovarik J; Boudny V; Kocak I; Lauerova L; Fait V; Vagundova M
    Int J Mol Med; 2003 Sep; 12(3):335-40. PubMed ID: 12883649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-type-I-mediated signaling is regulated by modulation of STAT2 nuclear export.
    Frahm T; Hauser H; Köster M
    J Cell Sci; 2006 Mar; 119(Pt 6):1092-104. PubMed ID: 16507591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-alpha activates Stat6 and leads to the formation of Stat2:Stat6 complexes in B cells.
    Gupta S; Jiang M; Pernis AB
    J Immunol; 1999 Oct; 163(7):3834-41. PubMed ID: 10490982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles virus activates NF-kappa B and STAT transcription factors and production of IFN-alpha/beta and IL-6 in the human lung epithelial cell line A549.
    Helin E; Vainionpää R; Hyypiä T; Julkunen I; Matikainen S
    Virology; 2001 Nov; 290(1):1-10. PubMed ID: 11882993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
    Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
    Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling.
    Takaoka A; Tanaka N; Mitani Y; Miyazaki T; Fujii H; Sato M; Kovarik P; Decker T; Schlessinger J; Taniguchi T
    EMBO J; 1999 May; 18(9):2480-8. PubMed ID: 10228162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.
    Garcia R; Yu CL; Hudnall A; Catlett R; Nelson KL; Smithgall T; Fujita DJ; Ethier SP; Jove R
    Cell Growth Differ; 1997 Dec; 8(12):1267-76. PubMed ID: 9419415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation.
    Cho SS; Bacon CM; Sudarshan C; Rees RC; Finbloom D; Pine R; O'Shea JJ
    J Immunol; 1996 Dec; 157(11):4781-9. PubMed ID: 8943379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to virus infection is determined by a Stat-mediated response to the autocrine effect of virus-induced type I interferon.
    Improta T; Pine R
    Cytokine; 1997 Jun; 9(6):383-93. PubMed ID: 9199872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol inhibits prolactin-induced activation of the JAK/STAT pathway in cultured astrocytes.
    DeVito WJ; Stone S
    J Cell Biochem; 1999 Aug; 74(2):278-91. PubMed ID: 10404396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of alpha-, beta- and gamma-interferon on the growth of breast cancer cell lines.
    Coradini D; Biffi A; Pirronello E; Di Fronzo G
    Anticancer Res; 1994; 14(5A):1779-84. PubMed ID: 7531412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.
    Kondo M; Nagano H; Wada H; Damdinsuren B; Yamamoto H; Hiraoka N; Eguchi H; Miyamoto A; Yamamoto T; Ota H; Nakamura M; Marubashi S; Dono K; Umeshita K; Nakamori S; Sakon M; Monden M
    Clin Cancer Res; 2005 Feb; 11(3):1277-86. PubMed ID: 15709199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.